نتایج جستجو برای: tumor class

تعداد نتایج: 816325  

Journal: :iranian journal of otorhinolaryngology 0
ali khalifeh department of otorhinolaryngology, mashhad university of medical sciences, mashhad, iran. mehdi bakhshaee sinus and surgical endoscopic research center, mashhad university of medical sciences, mashhad, iran. behrouz davachi department of radiology, mashhad university of medical sciences, mashhad, iran. leila mashhadi department of anesthesiology, mashhad university of medical sciences, mashhad, iran. kamran khazaeni department of otorhinolaryngology, mashhad university of medical sciences, mashhad, iran.

introduction: different imaging modalities are used to evaluate salivary gland diseases, including tumors. ultrasonography (us) is the preferred method on account of its ease of use, affordability, safety profile, and good tolerance among patients. the aim of this study was to evaluate the role of us in differentiating malignant from benign parotid tumors, in the context of previous controversy...

Journal: :basic and clinical neuroscience 0
shahab kamali ardekani alireza khoshnevisan ali shahbazi

introduction: notochord. although histologically benign, these tumors are locally aggressiveand present significant managment challenges . there arew some studies onevaluated the location, age and gender of the patients with chordoma in tworeferral centers in tehran.chordoma cases but there was no study about iranian cases. in this study weskull base chordomas are rare neoplasms arising from th...

2017
Wei Wang Chun-liang Shang Qi-qiao Du Di Wu Yan-chun Liang Tian-yu Liu Jia-ming Huang Shu-zhong Yao

Background & Aims: The long-term oncological outcome of Class I hysterectomy to treat stage IB1 cervical cancer is unclear. The aim of the present study was to compare the surgical and long-term oncological outcomes of Class I hysterectomy and Class III radical hysterectomy for treatment of stage IB1 cervical cancer (tumor ≤ 2 cm). Methods: Seventy stage IB1 cervical cancer patients (tumor ≤ 2 ...

Journal: :Seminars in cancer biology 2006
Chien-Chung Chang Soldano Ferrone

Malignant transformation of cells is frequently associated with HLA class I antigen downregulation or loss. This abnormality provides malignant cells with a mechanism to escape control by HLA class I antigen-restricted, tumor antigen-specific cytotoxic T lymphocytes. Surprisingly, HLA class I antigen downregulation or loss by tumor cells is not associated with control of tumor growth by natural...

Introduction: Glomus tympanicum (GT) is a benign primary tumor of the middle ear. The evolution of endoscopic ear surgery has allowed for an alternative approach to managing this vascular tumor. The purpose of this study was to evaluate an endoscopic approach in GT surgery, and also to investigate its applicability and feasibility.   Materials and Methods: Prospectively, 13 class I and II patie...

Journal: :Journal of immunology 2006
Doriana Fruci Silvia Ferracuti Maria Zaira Limongi Veronica Cunsolo Ezio Giorda Rocco Fraioli Leonardo Sibilio Oliver Carroll Akira Hattori Peter M van Endert Patrizio Giacomini

Peptide trimming in the endoplasmic reticulum (ER), the final step required for the generation of most HLA class I-binding peptides, implicates the concerted action of two aminopeptidases, ERAP1 and ERAP2. Because defects in the expression of these peptidases could lead to aberrant surface HLA class I expression in tumor cells, we quantitatively assayed 14 EBV-B cell lines and 35 human tumor ce...

2013
Yuxuan Liu Anke van den Berg Rianne Veenstra Bea Rutgers Ilja Nolte Gustaaf van Imhoff Lydia Visser Arjan Diepstra

Tumor cells of classical Hodgkin lymphoma (cHL) are characterized by a general loss of B cell phenotype, whereas antigen presenting properties are commonly retained. HLA class I is expressed in most EBV+ cHL cases, with an even enhanced expression in a proportion of the cases. Promyelocytic leukemia protein (PML) and special AT-rich region binding protein 1 (SATB1) are two global chromatin orga...

Journal: :Journal of the National Cancer Institute 1999
L A Koopman A R van Der Slik M J Giphart G J Fleuren

BACKGROUND Various mechanisms contribute to the loss of human leukocyte antigen (HLA) class I expression that is frequently observed in cancers. Although some single allele losses have been ascribed to mutations in HLA class I genes, direct evidence for this phenomenon in vivo is still lacking. Thus, we investigated whether HLA class I gene mutations could account for the loss of allele-specifi...

Journal: :Journal of immunology 2001
D I Gabrilovich M P Velders E M Sotomayor W M Kast

The mechanism of tumor-associated T cell dysfunction remains an unresolved problem of tumor immunology. Development of T cell defects in tumor-bearing hosts are often associated with increased production of immature myeloid cells. In tumor-bearing mice, these immature myeloid cells are represented by a population of Gr-1(+) cells. In this study we investigated an effect of these cells on T cell...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Eduard Ryschich Tanja Nötzel Ulf Hinz Frank Autschbach James Ferguson Ioan Simon Jürgen Weitz Boris Fröhlich Ernst Klar Markus W Büchler Jan Schmidt

PURPOSE Cell surface HLA class I molecules present peptides derived from human cellular proteins to T cells. In the present study, we investigated the expression of HLA class I in human pancreatic carcinoma. EXPERIMENTAL DESIGN The expression of HLA class I antigen and the extent of tumor infiltration by T cells were investigated in 46 primary tumors and in 14 metastases of pancreatic cancer ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید